The Rad-x group is specialised in diagnostic imaging including ultrasound, CT and MRI, the company has 24 centres based in Germany and Switzerland. Gilde Healthcare has built up Rad-x since 2016, they are a healthcare investor managing over EUR 2.6 billion across Venture & Growth and private equity.
Gilde Healthcare and other shareholders decided to sell their stake in the Rad-x holding company to a consortium of Swiss Life Asset Managers and Vesper. This will assist RAD-x to continue their growth through substantial plans to expand its footprint in current and new markets which Gilde Healthcare has left a strong foundation for.
CMS Hasge Sigle gave legal advice and support for Swiss Life Asset Managers throughout this deal.
Gilde Healthcare and the selling RAD-x shareholders were provided Belgian law legal advice from the law firm BoldLAW headed by Marijke Roelants.
“BoldLAW is proud to have assisted the shareholders of RAD-x SAS in the sale to Swiss Life Asset Managers and Vesper, highlighting its corporate expertise in complex international transactions and in-depth knowledge of Belgian law. With its pragmatic and client-focused approach, BoldLAW makes a tangible difference in every transaction.”
